IQVIA HOLDINGS INC. Income (Loss) from Equity Method Investments
IQVIA HOLDINGS INC. (IQV) reported Income (Loss) from Equity Method Investments of $6.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-05-05
- IQVIA HOLDINGS INC. income (loss) from equity method investments for the quarter ending 2026-03-31 was $6.00M.
- IQVIA HOLDINGS INC. income (loss) from equity method investments for the quarter ending 2025-12-31 was $36.00M, a 620.00% increase year-over-year.
- IQVIA HOLDINGS INC. income (loss) from equity method investments for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- IQVIA HOLDINGS INC. income (loss) from equity method investments for the quarter ending 2025-06-30 was -$1.00M, a 150.00% decline year-over-year.
- IQVIA HOLDINGS INC. income (loss) from equity method investments for fiscal 2025 was $22.00M, a 340.00% increase from fiscal 2024.
- IQVIA HOLDINGS INC. income (loss) from equity method investments for fiscal 2024 was $5.00M.
- IQVIA HOLDINGS INC. income (loss) from equity method investments for fiscal 2023 was $0.00.
- IQVIA HOLDINGS INC. income (loss) from equity method investments for fiscal 2022 was -$12.00M, a 300.00% decline from fiscal 2021.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 3 month as first filed | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 6 month as first filed | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 9 month as first filed | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $6.00M 10-Q · filed 2026-05-05 | $42.00M derived: sum of 2 quarters · filed 2026-05-05 | $42.00M derived: sum of 3 quarters · filed 2026-05-05 | $41.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-12-31 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $36.00M derived: sum of 2 quarters · filed 2026-02-17 | $35.00M derived: sum of 3 quarters · filed 2026-02-17 | $22.00M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-10-28 | -$1.00M derived: sum of 2 quarters · filed 2025-10-28 | -$14.00M 10-Q · filed 2025-10-28 | -$9.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-06-30 | -$1.00M 10-Q · filed 2025-07-22 | -$14.00M 10-Q · filed 2025-07-22 | -$9.00M derived: sum of 3 quarters · filed 2026-05-05 | -$8.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-03-31 | -$13.00M 10-Q · filed 2026-05-05 | -$8.00M derived: sum of 2 quarters · filed 2026-05-05 | -$7.00M derived: sum of 3 quarters · filed 2026-05-05 | -$5.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $6.00M derived: sum of 2 quarters · filed 2026-02-17 | $8.00M derived: sum of 3 quarters · filed 2026-02-17 | $5.00M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $1.00M 10-Q · filed 2025-10-28 | $3.00M derived: sum of 2 quarters · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 | -$6.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $2.00M 10-Q · filed 2025-07-22 | -$1.00M 10-Q · filed 2025-07-22 | -$7.00M derived: sum of 3 quarters · filed 2026-02-17 | -$2.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | -$3.00M 10-Q · filed 2025-05-06 | -$9.00M derived: sum of 2 quarters · filed 2026-02-17 | -$4.00M derived: sum of 3 quarters · filed 2026-02-17 | -$1.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$1.00M derived: sum of 2 quarters · filed 2026-02-17 | $2.00M derived: sum of 3 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $5.00M 10-Q · filed 2024-10-31 | $8.00M derived: sum of 2 quarters · filed 2024-10-31 | $6.00M 10-Q · filed 2024-10-31 | $6.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $3.00M 10-Q · filed 2024-07-22 | $1.00M 10-Q · filed 2024-07-22 | $1.00M derived: sum of 3 quarters · filed 2025-02-13 | -$6.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | -$2.00M 10-Q · filed 2024-05-02 | -$2.00M derived: sum of 2 quarters · filed 2025-02-13 | -$9.00M derived: sum of 3 quarters · filed 2025-02-13 | -$10.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$7.00M derived: sum of 2 quarters · filed 2025-02-13 | -$8.00M derived: sum of 3 quarters · filed 2025-02-13 | -$12.00M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | -$7.00M 10-Q · filed 2023-11-01 | -$8.00M derived: sum of 2 quarters · filed 2023-11-01 | -$12.00M 10-Q · filed 2023-11-01 | -$11.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | -$1.00M 10-Q · filed 2023-08-01 | -$5.00M 10-Q · filed 2023-08-01 | -$4.00M derived: sum of 3 quarters · filed 2024-02-15 | -$4.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$4.00M 10-Q · filed 2023-04-28 | -$3.00M derived: sum of 2 quarters · filed 2024-02-15 | -$3.00M derived: sum of 3 quarters · filed 2024-02-15 | -$2.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.00M derived: sum of 2 quarters · filed 2024-02-15 | $2.00M derived: sum of 3 quarters · filed 2024-02-15 | $6.00M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-10-27 | $1.00M derived: sum of 2 quarters · filed 2022-10-27 | $5.00M 10-Q · filed 2022-10-27 | $4.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $1.00M 10-Q · filed 2022-07-22 | $5.00M 10-Q · filed 2022-07-22 | $4.00M derived: sum of 3 quarters · filed 2023-02-15 | $7.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $4.00M 10-Q · filed 2022-04-28 | $3.00M derived: sum of 2 quarters · filed 2023-02-15 | $6.00M derived: sum of 3 quarters · filed 2023-02-15 | $5.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $2.00M derived: sum of 2 quarters · filed 2023-02-15 | $1.00M derived: sum of 3 quarters · filed 2023-02-15 | $7.00M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $3.00M 10-Q · filed 2021-10-22 | $2.00M derived: sum of 2 quarters · filed 2021-10-22 | $8.00M 10-Q · filed 2021-10-22 | $0.00 derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | -$1.00M 10-Q · filed 2021-07-28 | $5.00M 10-Q · filed 2021-07-28 | -$3.00M derived: sum of 3 quarters · filed 2022-02-16 | -$4.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | $6.00M 10-Q · filed 2021-04-23 | -$2.00M derived: sum of 2 quarters · filed 2022-02-16 | -$3.00M derived: sum of 3 quarters · filed 2022-02-16 | -$2.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$9.00M derived: sum of 2 quarters · filed 2022-02-16 | -$8.00M derived: sum of 3 quarters · filed 2022-02-16 | -$9.00M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | -$1.00M 10-Q · filed 2020-10-22 | $0.00 derived: sum of 2 quarters · filed 2020-10-22 | -$1.00M 10-Q · filed 2020-10-22 | $1.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $1.00M 10-Q · filed 2020-07-23 | $0.00 10-Q · filed 2020-07-23 | $2.00M derived: sum of 3 quarters · filed 2021-02-12 | $4.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | -$1.00M 10-Q · filed 2020-04-30 | $1.00M derived: sum of 2 quarters · filed 2021-02-12 | $3.00M derived: sum of 3 quarters · filed 2021-02-12 | $7.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $4.00M derived: sum of 2 quarters · filed 2021-02-12 | $8.00M derived: sum of 3 quarters · filed 2021-02-12 | $15.00M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $2.00M 10-Q · filed 2019-11-01 | $6.00M derived: sum of 2 quarters · filed 2019-11-01 | $13.00M 10-Q · filed 2019-11-01 | $16.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-06-30 | $4.00M 10-Q · filed 2019-07-24 | $11.00M 10-Q · filed 2019-07-24 | $14.00M derived: sum of 3 quarters · filed 2020-02-18 | $18.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-03-31 | $7.00M 10-Q · filed 2019-05-02 | $10.00M derived: sum of 2 quarters · filed 2020-02-18 | $14.00M derived: sum of 3 quarters · filed 2020-02-18 | $18.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $7.00M derived: sum of 2 quarters · filed 2020-02-18 | $11.00M derived: sum of 3 quarters · filed 2020-02-18 | $10.00M 10-K · filed 2020-02-18 | ||||
| 2017-09-30 | $4.00M 10-Q · filed 2018-10-25 | $8.00M derived: sum of 2 quarters · filed 2018-10-25 | $7.00M 10-Q · filed 2018-10-25 | $4.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-06-30 | $4.00M 10-Q · filed 2018-07-27 | $3.00M 10-Q · filed 2018-07-27 | $0.00 derived: sum of 3 quarters · filed 2019-02-19 | $195.00K derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-03-31 | -$1.00M 10-Q · filed 2018-05-04 | -$4.00M derived: sum of 2 quarters · filed 2019-02-19 | -$3.81M derived: sum of 3 quarters · filed 2019-02-19 | -$7.80M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2016-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$2.81M derived: sum of 2 quarters · filed 2019-02-19 | -$6.80M derived: sum of 3 quarters · filed 2019-02-19 | -$4.00M 10-K · filed 2019-02-19 | ||||
| 2016-09-30 | $195.00K 10-Q · filed 2016-11-03 | -$3.81M derived: sum of 2 quarters · filed 2017-08-04 | -$1.00M 10-Q · filed 2017-10-27 | -$952.00K 10-Q · filed 2016-11-03 | -$803.00K derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-06-30 | -$4.00M 10-Q · filed 2017-08-04 | -$3.79M 10-Q · filed 2016-07-27 | -$1.00M 10-Q · filed 2017-08-04 | -$1.15M 10-Q · filed 2016-07-27 | -$998.00K derived: sum of 3 quarters · filed 2018-02-16 | $4.36M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | $3.00M 10-Q · filed 2017-05-08 | $2.64M 10-Q · filed 2016-05-03 | $3.00M derived: sum of 2 quarters · filed 2018-02-16 | $8.36M derived: sum of 3 quarters · filed 2018-02-16 | $10.09M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $5.36M derived: sum of 2 quarters · filed 2018-02-16 | $7.09M derived: sum of 3 quarters · filed 2018-02-16 | $8.00M 10-K · filed 2018-02-16 | $8.30M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $5.36M 10-Q · filed 2016-11-03 | $7.09M derived: sum of 2 quarters · filed 2016-11-03 | $8.00M 10-Q · filed 2016-11-03 | $3.21M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $1.73M 10-Q · filed 2016-07-27 | $2.64M 10-Q · filed 2016-07-27 | -$2.15M derived: sum of 3 quarters · filed 2017-02-16 | -$626.00K derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $911.00K 10-Q · filed 2016-05-03 | -$3.87M derived: sum of 2 quarters · filed 2017-02-16 | -$2.35M derived: sum of 3 quarters · filed 2017-02-16 | $1.02M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | -$4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$3.26M derived: sum of 2 quarters · filed 2017-02-16 | $109.00K derived: sum of 3 quarters · filed 2017-02-16 | $5.00M 10-K · filed 2017-02-16 | $4.37M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $1.52M 10-Q · filed 2015-10-28 | $4.89M derived: sum of 2 quarters · filed 2015-10-28 | $9.79M 10-Q · filed 2015-10-28 | $10.23M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $3.37M 10-Q · filed 2015-07-29 | $8.26M 10-Q · filed 2015-07-29 | $8.71M derived: sum of 3 quarters · filed 2016-02-11 | $8.36M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $4.89M 10-Q · filed 2015-04-29 | $5.34M derived: sum of 2 quarters · filed 2016-02-11 | $4.99M derived: sum of 3 quarters · filed 2016-02-11 | $5.45M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $450.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $95.00K derived: sum of 2 quarters · filed 2016-02-11 | $559.00K derived: sum of 3 quarters · filed 2016-02-11 | -$1.12M 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | -$355.00K 10-Q · filed 2014-10-30 | $109.00K derived: sum of 2 quarters · filed 2014-10-30 | -$1.57M 10-Q · filed 2014-10-30 | -$1.81M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $464.00K 10-Q · filed 2014-07-31 | -$1.22M 10-Q · filed 2014-07-31 | -$1.46M derived: sum of 3 quarters · filed 2015-02-12 | -$559.00K derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | -$1.68M 10-Q · filed 2014-05-01 | -$1.92M derived: sum of 2 quarters · filed 2015-02-12 | -$1.02M derived: sum of 3 quarters · filed 2015-02-12 | -$689.00K derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | -$236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $660.00K derived: sum of 2 quarters · filed 2015-02-12 | $994.00K derived: sum of 3 quarters · filed 2015-02-12 | $2.57M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $896.00K 10-Q · filed 2013-10-31 | $1.23M derived: sum of 2 quarters · filed 2013-10-31 | $2.80M 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $334.00K 10-Q · filed 2013-08-01 | $1.91M 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | $1.57M 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | $70.76M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |